How neonatal mortality is stalling -- and why that should concern all of us
The fight against child mortality has produced spectacular results over the past few decades. But for newborns, progress is in danger of grinding to a halt. The easiest lives have been saved; what remains are the hardest cases, and the political will to pay for them is crumbling.
Every year, around 2.3 million babies still die within the first four weeks of life. That is a decline compared with two decades ago, but the curve is visibly flattening. According to an analysis published in Science, we have moved past the era of "low-hanging fruit": the interventions that could most easily save lives -- oral rehydration therapy, basic vaccinations, essential obstetric care -- have largely been rolled out. What remains are cases that require intensive neonatal care: premature babies, severe infections, congenital abnormalities. These cost more, demand more infrastructure, and attract far less political attention.
The funding is drying up
The timing could hardly be worse. International health programs are under pressure worldwide from budget cuts and political shifts. Programs targeting maternal and child health in low-income countries -- once a relatively broadly supported priority -- are losing funding. The technical knowledge needed to drive neonatal mortality down further exists; what is missing is the structural investment to put that knowledge into practice at scale. There is a certain irony here: neonatal mortality is also a longevity problem. Every child who survives the first month of life has, in principle, decades of potentially healthy years ahead. Investments at this stage are investments in the total number of healthy life-years within a population.
There is a demographic dimension to this as well. In countries with high neonatal mortality, the population skews young, and the potential for economic development is directly tied to the health of the youngest generation. Stalling neonatal survival is not merely a humanitarian problem -- it has consequences for labor markets, health systems, and social stability over the long term. The question is not whether we have the means to tackle this. The question is whether we are willing to make it a political priority.